Completed PHASE1 INTERVENTIONAL 2-arm NCT04417543

Effect of Memantine on Cognitive Impairment in Patients With Epilepsy

Sponsor: Assiut University

Conditions Epilepsy

Interventions Memantine Hydrochloride Placebo

Updated 5 times since 2020 Last updated: Jun 3, 2020 Started: Oct 1, 2018 Primary completion: Oct 1, 2019 Completion: Jan 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Epilepsy, this trial is completed. The trial is conducted by Assiut University and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jul 2020 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt